期刊
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY
卷 22, 期 2, 页码 112-118出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MED.0000000000000138
关键词
acyltransferase; arachidonic acid; lipid mediators; phospholipase A(2); phospholipids
资金
- Canadian institutes of Health Research [160550]
- Atlantic Innovation Fund [201211]
- Canadian Breast Cancer Foundation Atlantic [R13F13]
- New Brunswick Innovation Research Chair in Biosciences
- Canadian Institutes of Health Research
- New Brunswick Health Research Foundation
Purpose of review To highlight some of the recent advances related to the control of polyunsaturated fatty acid (PUFA) incorporation and remodeling in membrane glycerophospholipids in inflammatory cells. Recent findings Several enzymes have recently been identified that are associated with the control of PUFA incorporation and remodeling into membrane phospholipids and their release. The functional roles of the different enzyme isotypes in the control of PUFA availability for lipid mediator biosynthesis and cell signaling are only now being established. The expression of specific acyl-CoA synthetase, lysophospholipid acyltransferase and phospholipase A(2) isotypes has recently been shown to have an impact on membrane PUFA content, on the production of lipid mediators and on inflammation. Summary A better understanding of the complex processes associated with the control PUFA remodeling in membrane phospholipids may lead to the discovery of new therapeutic targets for the treatment of inflammatory diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据